FDA Inspection
Interstate Blood Bank Inc of MissouriInterstate Blood Bank Inc of Missouri – FDA Inspection, Feb 16, 2011
Record Details
This FDA Inspection record concerns Interstate Blood Bank Inc of Missouri, with an inspection on February 16, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- February 16, 2011
- Product Type
- Biologics
View Company Profile
ID · 2803d261-8121-4007-8546-f6ca77f60f52
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 714457
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 606.100(b)(2)Donor qualifying tests & measurements
- 21 CFR 606.170(a)Adverse Reaction- Reports of Investigations
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Interstate Blood Bank Inc of Missouri
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 30, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 20, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Interstate Blood Bank Inc of Missouri
- FDA Inspection 1118732 - 2020-01-30
- FDA Inspection 1000593 - 2017-01-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.